• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.

Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial. Am J Transplant. 2013 May; 13(5):1203-16.

View in: PubMed

subject areas
  • Acute Disease
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antineoplastic Agents
  • Asia
  • Australia
  • Biopsy
  • Dose-Response Relationship, Drug
  • Europe
  • Everolimus
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Heart Transplantation
  • Humans
  • Immunosuppressive Agents
  • Incidence
  • Male
  • Middle Aged
  • Mycophenolic Acid
  • Myocardium
  • North America
  • Prospective Studies
  • Sirolimus
  • South America
  • Treatment Outcome
  • Ultrasonography, Interventional

authors with profiles
  • Adrian B. Van Bakel